Page last updated: 2024-09-04

atractylenolide iii and Breast Cancer

atractylenolide iii has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, J; Ke, X; Liu, T; Lu, H; Ma, J; Tan, S; Wang, S	1

Other Studies

1 other study(ies) available for atractylenolide iii and Breast Cancer

Article	Year
The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells. Oncology reports, 2016, Volume: 35, Issue:1 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lactones; Mice; Neoplasm Metastasis; Sesquiterpenes; Signal Transduction; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays	2016

Article

Year

The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.

Oncology reports, 2016, Volume: 35, Issue:1

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lactones; Mice; Neoplasm Metastasis; Sesquiterpenes; Signal Transduction; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2016